You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞(01548.HK)新加坡提供新冠病毒中和抗體檢測試劑盒
阿思達克 04-13 15:24
金斯瑞生物科技(01548.HK)公布,與Parkway Laboratories及Diagnostics Development(DxD) Hub合作,將通過Parkway的專家小組及全科醫生診所,在新加坡提供cPass新冠病毒中和抗體檢測試劑盒。

公司表示,該產品由杜克-新加坡國立大學醫學院(Duke-NUS)、金斯瑞和DxD Hub聯合開發,已獲得新加坡衛生科學局的臨時授權以及歐盟CE-IVD認證,並獲得美國食品藥品監督管理局的緊急使用授權,可以檢測功能性中和抗體,而且得出結果時間較短,僅約一小時,適用於高通量和全自動化檢測。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account